Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-10-12

Clinical Trial Update: Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen [Phase 4]

View source ↗

Summary

Phase 4 trial update assessing safety and efficacy of trastuzumab as part of a breast cancer treatment regimen.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Trastuzumab (trastuzumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Breast Cancer | Phase 4 | Status: COMPLETED | Results posted: 2022-10-12